AI predicts stomach cancer response to chemo
Part of Cancer, Digestive system clinical trials.
This trial tests a computer-based model that uses CT scans, endoscopic images, and biopsy tissue to predict how well stomach cancer will respond to chemotherapy given before surgery. The goal is to help doctors choose the best treatment for each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have stomach or esophageal-stomach junction cancer confirmed by a tissue sample (biopsy).
- You must have received chemotherapy before surgery, and then had surgery to remove the cancer.
- Before any treatment started, you must have had a CT scan, an endoscopy, and a biopsy of the tumor.
- The tumor must be measurable based on standard cancer assessment guidelines (RECIST 1.1).
- Your CT scan must show the tumor clearly (stomach must be properly filled with liquid or air).
- The biopsy sample must be large enough to see the cancer cells clearly under a microscope.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
This trial uses advanced imaging (ultrasound and CT) plus a blood test to predict how well your stomach cancer will respond to chemotherapy given before surgery. The goal is to personalize your treatment and improve outcomes.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This study uses artificial intelligence to analyze your CT scan and predict whether stomach cancer has spread to lymph nodes behind your belly. The goal is to help doctors decide if you need more extensive surgery.
This study uses information from CT scans done before stomach cancer surgery to see if it can predict whether the cancer may come back early. Researchers want to find patterns in the scans that might help doctors plan better follow-up care.
This study looks at CT scans and clinical information from people with stomach cancer to see if they can help predict how the disease will progress. It may help doctors better understand each patient's situation.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.